Grandlin Capsule

Grandlin Capsule is a fixed-dose combination of pregabalin used for neuropathic pain, while methylcobalamin, an active form of Vitamin B12, is essential for nerve myelination and repair. Grandlin Capsule is one of the common medicines used to manage peripheral neuropathic pain, especially in people suffering from diabetic peripheral neuropathy, post-herpetic neuralgia, sciatica, spinal radiculopathy, and other nerve injury syndromes. Pregabalin reduces abnormal nerve firing and pain signal transmission, while methylcobalamin supports nerve regeneration and addresses the Vitamin B12 deficiency that frequently coexists with peripheral neuropathy.

Grandlin Capsule is a structural analogue of gamma-aminobutyric acid (GABA). It is available in the form of oral capsules or tablets, typically containing pregabalin with methylcobalamin, which is also available in sustained-release formulations. The combination addresses two complementary aspects of neuropathic pain: pregabalin reduces the abnormal pain signalling itself, while methylcobalamin supports the underlying repair of damaged nerve fibres.

Pregabalin is approved for diabetic peripheral neuropathy, post-herpetic neuralgia, fibromyalgia, neuropathic pain associated with spinal cord injury, and adjunctive therapy of partial-onset seizures. It binds to the alpha-2-delta subunit of voltage-gated calcium channels in central neurons, reducing the release of excitatory neurotransmitters, thereby damping abnormal pain signalling. Methylcobalamin is the methylated active form of cobalamin and is required for myelination, methionine synthase activity, and nerve regeneration.

Diabetic peripheral neuropathy

It is commonly used for the management of painful diabetic neuropathy, particularly when B12 deficiency is suspected alongside.

Post-herpetic neuralgia

Persistent burning or stabbing pain after shingles.

Sciatica and lumbar/cervical radiculopathy

Grandlin Capsule helps in managing nerve root pain from disc disease or spinal stenosis.

Other peripheral neuropathies

Including alcohol-related, drug-induced (chemotherapy), and idiopathic peripheral neuropathy.

Trigeminal neuralgia

Grandlin Capsule is often used to manage pain when carbamazepine is contraindicated or proves to be ineffective.

Fibromyalgia

Pregabalin helps chronic widespread pain.

• Combines symptomatic pain relief with nerve regeneration support in a single tablet.

• Effective in painful diabetic peripheral neuropathy, with significant pain reduction often within weeks.

• Methylcobalamin improves nerve conduction velocity and addresses the B12 deficiency commonly associated with peripheral neuropathy.

• Helps manage symptoms like sleep disturbance, paraesthesia, burning, tingling, and numbness.

• Pregabalin has predictable pharmacokinetics, no major drug-drug interactions, and is renally excreted unchanged.

• Methylcobalamin is the active form of B12, requiring no further conversion in the body.

• Generally well tolerated without any serious adverse effects at standard doses.

Common:

• Dizziness, sleepiness, drowsiness

• Weight gain

• Peripheral oedema (swelling due to fluid buildup)

• Dry mouth, blurred vision

• Headache, fatigue

• Constipation

• Mild gastrointestinal upset

Uncommon

• Confusion, irritability, mood changes

• Tremor, difficulty concentrating

• Sexual dysfunction

• Hyperglycaemia

• Skin rash or itching

Serious side effects requiring immediate attention

• Suicidal behaviour (class effect of antiepileptic drugs)

• Severe allergic reactions, angioedema (swelling of face, lips, tongue, throat)

• Respiratory depression (breathing too slow or too shallow), especially when combined with opioids or other CNS depressants

• Severe dizziness with falls (especially in older adults)

• Withdrawal symptoms on abrupt discontinuation may include insomnia, nausea, headache, anxiety, sweating, & seizures (rare)

Take Grandlin Capsule orally exactly as prescribed, with or without food. The pregabalin component is typically initiated at a lower dose and then titrated upwards in divided doses, depending on response and tolerability. Sustained-release formulations are taken once daily. Swallow capsules or tablets whole with water; do not crush or chew sustained-release forms. Do not exceed the prescribed dose. Avoid alcohol and CNS depressants while taking Grandlin Capsule. Avoid driving or operating machinery until you know how the drug affects you. Do not stop Grandlin Capsule abruptly, as it may result in withdrawal symptoms. Always taper gradually under medical supervision.

Neuropathic pain arises when damaged or dysfunctional nerves fire abnormally, sending false pain signals to the brain. The damage may come from diabetes (high glucose toxicity), shingles (herpes zoster virus), nerve root compression, chemotherapy, or other causes. The two components of Grandlin Capsule address this in complementary ways.

Pregabalin is a structural analogue of GABA but does not bind to GABA receptors. Instead, it binds to the alpha-2-delta subunit of voltage-gated calcium channels (Cav alpha-2-delta) on presynaptic neurons in the central nervous system. This reduces calcium influx into the nerve terminal during depolarisation, which in turn reduces the release of excitatory neurotransmitters into the synapse. This reduces abnormal pain signalling along the spinal cord and into the brain, producing pain relief and reducing associated symptoms such as paraesthesia (numbness) and sleep disturbance.

Methylcobalamin is the active, methylated form of Vitamin B12. It is a cofactor for methionine synthase, which converts homocysteine to methionine and provides methyl groups required for the synthesis and maintenance of myelin. Myelin is the protective sheath around nerve fibres that is essential for proper nerve conduction. In peripheral neuropathy, the myelin sheath and axon are often damaged. Methylcobalamin supports myelin regeneration, axonal repair, and overall nerve function, particularly in patients with documented or subclinical B12 deficiency.

• Food (NIL): Pregabalin can be taken with or without food.

• Alcohol (SEVERE): Significantly increases sedation, dizziness, and respiratory depression. Avoid.

• High-fat meals (MILD): Slightly slow pregabalin absorption but no clinically meaningful effect.

Opioids (morphine, oxycodone, tramadol)

SEVERE

Heightened risk of respiratory depression, sedation, and death. Do not use until prescribed.

Benzodiazepines (alprazolam, diazepam, lorazepam)

SEVERE

Additional sedation and respiratory depression.

Other CNS depressants (sedatives, hypnotics, alcohol)

SEVERE

Additional sedation. Do not use until prescribed.

Antihypertensives

MODERATE

Additional risk of dizziness and orthostatic hypotension.

Thiazolidinediones (pioglitazone, rosiglitazone)

MODERATE

Additional risk of peripheral oedema and weight gain.

ACE inhibitors

CAUTION

Pregabalin may increase the risk of angioedema.

Metformin

MILD

Long-term metformin reduces B12 absorption.

Chloramphenicol

CAUTION

May blunt haematopoietic response to B12.

Antiepileptic drugs

MODERATE

Additional risk of sedation. Do not use until prescribed.

• Renal impairment (CAUTION): Dose reduction would be required as Grandlin Capsule is excreted through the kidneys.

• Heart failure (CAUTION): High risk of worsening oedema.

• History of substance use disorder(CAUTION): Pregabalin abuse potential. Do not go beyond the prescribed dosage & frequency.

• Severe respiratory disease (COPD, sleep apnoea) (CAUTION): Risk of respiratory depression, especially with opioids.

• Diabetes (MODERATE): May cause weight gain and rare hyperglycaemia. Monitor blood glucose frequently.

• Leber's hereditary optic neuropathy (MILD): High-dose cyanocobalamin has been associated with worsening. Consult a specialist for the appropriate dosage.

Take a missed dose as soon as you remember, unless it is close to the time of the next dose. In this case, skip it and continue with your normal schedule. Do not double-dose. If you miss several doses, contact your doctor before resuming, as you may need to re-titrate. Consistent dosing matters for sustained pain relief and to avoid withdrawal-like symptoms.

Pregabalin overdose may present as severe drowsiness, confusion, ataxia (poor muscle control), slurred speech, restlessness, and, in severe cases, coma, respiratory depression, or seizures. Methylcobalamin has no clinically defined toxicity at supplemental doses. Management may involve stabilising the airway, breathing, and circulation, haemodialysis to remove pregabalin (about 50% in 4 hours) in a significant overdose, and using activated charcoal for recent ingestion. Cardiac and respiratory monitoring is required. Seek immediate emergency care if overdose is suspected.